S&P TSX Capped Composite...

US Dollar vs CAD

Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Get Started

LCTX Lineage Cell Therapeutics Inc

0.552

0.05 (9.96%)

Dec 20 2024 - Closed

Delayed by 15 minutes

Form SC 13G - Statement of Beneficial Ownership by Certain Investors

Lineage Cell Therapeutics (AMEX:LCTX)
Historical Stock Chart
From Nov 2024 to Dec 2024

Click Here for more Lineage Cell Therapeutics Charts.

Lineage Cell Therapeutics (AMEX:LCTX)
Historical Stock Chart
From Dec 2023 to Dec 2024

Click Here for more Lineage Cell Therapeutics Charts.

Lineage Cell Therapeutics Inc News

Form DEF 14A - Other definitive proxy statements
Monday 9 December 2024 (2 weeks ago) • Edgar (US Regulatory)

Form PRE 14A - Other preliminary proxy statements
Friday 29 November 2024 (3 weeks ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 26 November 2024 (4 weeks ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Monday 25 November 2024 (4 weeks ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Friday 22 November 2024 (1 month ago) • Edgar (US Regulatory)

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
Thursday 21 November 2024 (1 month ago) • Edgar (US Regulatory)

Lineage Cell Therapeutics Announces First Closing of up to $66 Million Registered Direct Offering
Thursday 21 November 2024 (1 month ago) • Business Wire

Form 424B5 - Prospectus [Rule 424(b)(5)]
Thursday 21 November 2024 (1 month ago) • Edgar (US Regulatory)

Form 8-K - Current report
Wednesday 20 November 2024 (1 month ago) • Edgar (US Regulatory)

Lineage Cell Therapeutics Announces Pricing of up to $66 Million Registered Direct Offering
Wednesday 20 November 2024 (1 month ago) • Business Wire

Form 8-K - Current report
Thursday 14 November 2024 (1 month ago) • Edgar (US Regulatory)

Lineage Cell Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update
Thursday 14 November 2024 (1 month ago) • Business Wire

More Lineage Cell Therapeutics Inc News Articles

Anavex Life Sciences

Asia Broadband (PK)

Lightwave Logic

Digital Brand Media and ... (PK)

Bioelectronics (PK)

Elite Pharmaceuticals (QB)

Good Vibrations Shoes (PK)

Northwest Biotherapeutics (QB)

Fannie Mae (QB)

Kraig Biocraft Laborator... (QB)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions